Based on quantitative, time‐resolved data, we showed that dependent on the IFNα dose prestimulation of hepatoma cell lines and primary human hepatocytes with IFNα leads to desensitization or hypersensitization of pathway activation and thereby the antiviral response. The gene discussed is IFNA17; the disease is hepatocellular carcinoma.